SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)

被引：0

作者：

Mak, Ka-Man ^{[1
]}

McDonald, Fiona ^{[2
]}

Teague, Jonathan ^{[3
]}

Faivre-Finn, Corinne ^{[4
,5
]}

Forster, Martin ^{[6
,7
]}

Hanna, Gerard ^{[8
]}

Moinuddin, Syed ^{[6
]}

Conibear, John ^{[9
]}

Harden, Susan ^{[10
]}

Popat, Sanjay ^{[11
]}

Califano, Raffaele ^{[12
,13
]}

Farrelly, Laura ^{[3
]}

Counsell, Nicholas ^{[3
]}

Saron, T. M. G. ^{[3
]}

机构：

[1] CR UK & UCL Canc Trials Ctr, London, England

[2] Royal Marsden Hosp, London, England

[3] Canc Res UK & UCL Canc Trials Ctr, London, England

[4] Christie NHS Fdn Trust, Manchester, Lancs, England

[5] Univ Manchester, Manchester, Lancs, England

[6] Univ Coll London Hosp NHS Fdn Trust, London, England

[7] UCL, London, England

[8] Belfast City Hosp, Canc Ctr, Belfast, Antrim, North Ireland

[9] St Bartholomews Hosp, London, England

[10] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[11] Royal Marsden Hosp, London, England

[12] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[13] Univ Manchester, Manchester, Lancs, England

来源：

LUNG CANCER | 2022年 / 165卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

155

引用

页码：S71 / S71

页数：1

共 50 条

[1] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
McDonald, F.
Mak, K. M.
Teague, J.
Landau, D.
Hanna, G.
Farrelly, L.
Counsell, N.
[J]. LUNG CANCER, 2020, 139 : S91 - S91
[2] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial
Ngai, Yenting
Hanna, Gerard
Conibear, John
Counsell, Nicholas
Hughes, Laura
Farrelly, Laura
Landau, David
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1425 - S1426
[3] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial
Landau, D. B.
Hughes, L.
Ngai, Y.
Hanna, G. G.
Conibear, J.
Farrelly, L.
Counsell, N.
[J]. LUNG CANCER, 2017, 103 : S54 - S54
[4] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
Verma, Vivek
Chang, Joe Y.
[J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
[5] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
Dohopolski, Michael
Iyengar, Puneeth
[J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
[6] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
Ricardi, Umberto
Levra, Niccolo Giaj
Badellino, Serena
Alongi, Filippo
[J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
[7] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
Suh, Yang-Gun
Cho, Jaeho
[J]. RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
[8] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
Leschenko, Y.
Chebotareva, T.
Spizhenko, N.
Fedusenko, A.
Sharaevskiy, O.
Buryk, V.
[J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
[9] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
Song, Andrew
Lu, Bo
[J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
[10] Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report
Leduc, C.
Antoni, D.
Quoix, E.
Noel, G.
[J]. CANCER RADIOTHERAPIE, 2015, 19 (03): : 192 - 197

← 1 2 3 4 5 →